3种无创诊断技术对慢性乙型肝炎肝纤维化的评估价值比较

庄小芳; 马燕; 王晓忠; 王燕; 郭峰; 王晓波

doi:10.3969/j.issn.1001-5256.2016.08.015

3种无创诊断技术对慢性乙型肝炎肝纤维化的评估价值比较

DOI: 10.3969/j.issn.1001-5256.2016.08.015

新疆维吾尔自治区中医医院肝病科

基金项目:

新疆医科大学科研创新基金(ZYY201325)；

详细信息

中图分类号: R512.62;R575.2
计量
- 文章访问数: 2522
- HTML全文浏览量: 43
- PDF下载量: 531
- 被引次数: 0
出版历程
- 收稿日期: 2016-02-25
- 出版日期: 2016-08-20

The predictive values of three noninvasive indices in diagnosis of liver fibrosis in patients with chronic hepatitis B: a comparative study

Department of Hepatology,Traditional Chinese Medicine Hospital of Xinjiang Uygur Autonomous Region

Research funding:

摘要

摘要: 目的探讨Fibro Touch、FIB-4指数、APRI指数3种肝纤维化无创诊断技术对慢性乙型肝炎（CHB）肝纤维化评估的价值。方法纳入2013年9月-2015年5月在新疆维吾尔自治区中医医院就诊的148例行肝穿刺活组织检查的CHB患者,以肝纤维化分期分组,均进行血生化、血常规、Fibro Touch检测,计算FIB-4指数和APRI指数,记录肝脏硬度值,应用受试者工作特征曲线（ROC）分析方法计算曲线下面积（AUC）,确定截断值、敏感度和特异度。两组间比较采用χ2检验;相关性检验采用Pearson等级相关分析。结果 Fibro Touch、APRI和FIB-4指数3种无创诊断方法与肝纤维化分期具有良好的相关性（r值分别为0.628、0.486、0.482,P值均<0.01）。Fibro Touch对明显肝纤维化组（≥S2）、肝硬化组（S4）的诊断性能最好,AUC分别为0.84、0.93;其次为APRI指数,AUC分别为0.79、0.87;FIB-4指数诊断性能相对较差,AUC分别为0.77、0.84。对于肝纤维化分期≥S2及S4,FibroTouch诊断价值均优于APRI及FI...
- 肝硬化 /
- 肝炎,乙型,慢性 /
- 诊断技术和方法 /
- 对比研究
Abstract: Objective To investigate the values of Fibro Touch,FIB- 4 index,and aspartate aminotransferase- to- platelet ratio index( APRI) in the diagnosis of liver fibrosis in patients with chronic hepatitis B( CHB). Methods A total of 148 patients with CHB who visited Traditional Chinese Medicine Hospital of Xinjiang Uygur Autonomous Region and underwent liver biopsy from September 2013 to May2015 were enrolled and divided into groups according to fibrosis stage. All the patients underwent blood biochemical examination,routine blood tests,and Fibro Touch measurement. Then FIB- 4 and APRI were calculated,and liver stiffness was recorded. The receiver operating characteristic( ROC) curve was used to calculate the area under the ROC curve( AUC) and determine the cut- off value,sensitivity,and specificity. Chi- square test was used for comparison between two groups,and the Pearson rank correlation analysis was also performed. Results Fibro Touch,APRI,and FIB- 4 were well correlated with fibrosis stage( r = 0. 628,0. 486,and 0. 482,respectively,all P < 0. 01).In the marked liver fibrosis( ≥S2) group and liver cirrhosis( S4) group,Fibro Touch had the best diagnostic performance,with AUCs of 0. 84 and 0. 93,respectively,followed by APRI,which had AUCs of 0. 79 and 0. 87,respectively; FIB- 4 index had the worst diagnostic performance,with AUCs of 0. 77 and 0. 84,respectively. In patients with a fibrosis stage of ≥S2 or S4,Fibro Touch had a better diagnostic value than APRI and FIB- 4( Z = 21. 589,P < 0. 001; Z = 18. 896,P < 0. 001; Z = 11. 192,P = 0. 001; Z = 16. 891,P < 0. 001),and APRI had a better diagnostic value than FIB- 4( Z = 46. 918,P < 0. 001; Z = 35. 334,P < 0. 001). Conclusion Fibro Touch can accurately evaluate the presence of liver fibrosis and fibrosis degree and help most patients avoid invasive liver biopsy.
- liver cirrhosis /
- hepatitis B /
- chronic /
- diagnostic techniques and procedures

HTML全文

参考文献(17)

[1]HOU FF,QI XS.Elastography assessment of liver fibrosis:society of radiologists in ultrasound consensus conference statement[J].J Clin Hepatol,2015,31(9):1384-1388.(in Chinese)侯飞飞,祁兴顺.《2015年美国超声放射医师学会共识声明:弹性成像评估肝纤维化》摘译[J].临床肝胆病杂志,2015,31(9):1384-1388.

[2]HU XY,LIU ZH,SUN J,et al.Explanation of the“Guidelines for the prevention,care and treatment of persons with chronic hepatitis B infection 2015”:non-invasive assessment of liver fibrosis,treatment strategy and implementation of national programs[J].J Clin Hepatol,2015,31(6):829-832.(in Chinese)胡晓云,刘智泓,孙剑,等.《2015年世界卫生组织慢性乙型肝炎病毒感染预防、关怀和治疗指南》解读:无创肝纤维化评估、抗病毒治疗策略和国家防治计划实施[J].临床肝胆病杂志,2015,31(6):829-832.

[3]European Association for the Study of the Liver.EASL clinical practice guidelines:management of chronic hepatitis B virus infection[J].J Hepatol,2012,57(1):167-185.

[4]LIAW YF,KAO JH,PIRATVISUTH T,et a I.Asian-Pacific consensus statement on the management of chronic hepatitis B:a 2012 update[J].Hepatol Int,2012,6(3):531-561.

[5]CHEN Y,PENG J,HOU J.Non-invasive assessment of liver fibrosis in patients with chronic hepatitis B[J].Hepatol Int,2013,7(2):356-368.

[6]Chinese Society of Hepatology,Chinese Society of Infectious Diseases,Chinese Medical Association.The guideline of prevention and treatment for chronic hepatitis B(2010 version)[J].Chin J Infect Dis,2011,29(2):65-80.(in Chinese)中华医学会肝病学分会,中华医学会感染病学分会.慢性乙型肝炎防治指南(2010版)[J].中华传染病杂志,2011,29(2):65-80.

[7]STERLING RK,LISSEN E,CLIMENCK N,et al.Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection[J].Hepatology,2006,43(6):1317-1325.

[8]WAI CT,GREENSON JK,FONTANAL RJ,et al.A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C[J].Hepatology,2003,38(2):518-526.

[9]WANG YJ,TANG SS.Assessment of hepatic fibrosis stage by transient elastography:an Meta-analysis[J].Chin J Med Imaging Technol,2012,28(3):529-533.(in Chinese)王一娇,唐少珊.瞬时弹性成像评价肝纤维化分级的Meta分析[J].中国医学影像技术,2012,28(3):529-533.

[10]TREMBLING PM,LAMPERTICO P,PARKES J,et al.Performance of enhanced liver fibrosis test and comparison with transient elastography in the identification of liver fibrosis in patients with chronic hepatitis B infection[J].J Viral Hepat,2014,21(6):430-438.

[11]FEDERICA B,CLARA BC,ALESSANDRA B,et al.Non-invasive assessment of liver fibrosis in chronic hepatitis B[J]:World J Gastroenterol,2014,20(40):14568-14580.

[12]XIAO G,YANG J,YAN L.Comparison of diagnostic accuracy of aspartate aminotransferase-to-platelet ratio index and fibrosis-4 index for detecting liver fibrosis in adult patients with chronic hepatitis B virus infection:a systemic review and meta-analysis[J].Hepatolgy,2015,61(1):292-302.

[13]OU XJ,WANG XM,WU XN,et al.Comparison of Fibro Touch and Fibro Scan for the assessment of fibrosis in chronic hepatitis B patients[J].Chin J Hepatol,2015,23(2):103-106.(in Chinese)欧晓娟,王晓明,吴晓宁,等.Fibro Touch与Fibro Scan在慢性乙型肝炎患者肝纤维化评估中的比较[J].中华肝脏病杂志,2015,23(2):103-106.

[14]LIU J,LIU YX,DONG CF,et al.ARFI,Forns index,FIB-4and APRI diagnosis liver ifbrosis in patients with chronic liver diseases[J/CD].Chin J Liver Dis:Electronic Edition,2014,6(1):18-21.(in Chinese)刘京,刘映霞,董常峰,等.ARFI、Forns指数、FIB-4和APRI无创诊断慢性乙型病毒性肝炎肝纤维化的研究[J/CD].中国肝脏病杂志:电子版,2014,6(1):18-21.

[15]SINGH S,FUJILL L,MURAD MH,et al.Liver stiffness is associated with risk of decompensation,liver cancer,and death in patients with chronic liver diseases:a systematic review and meta-analysis[J].Clin Gastroenterol Hepatol,2013,11(12):1573-1584.

[16]TAN YJ,JI D,NIU XX,et al.Frequncy and determinants of liver stiffness measurement failure[J].J Med Res,2012,41(11):30-33.(in Chinese)谭有娟,纪冬,牛小霞,等.瞬时弹性成像检测肝硬度失败的因素及分析[J].医学研究杂志,2012,41(11):30-33.

[17]Expert Committee on Clinical Application of Transient Elastography.Expert consensus on clinical application of transient elastography(TE)(2015)[J/CD].Chin J Liver Dis:Electronic Edition,2015,2(7):12-18.(in Chinese)瞬时弹性成像技术临床应用专家委员会.瞬时弹性成像技术(TE)临床应用专家共识(2015年)[J/CD].中国肝脏病杂志:电子版,2015,2(7):12-18.

施引文献

资源附件(0)

访问统计